March 23, 2020 / 12:20 PM / 8 days ago

BRIEF-Hoth Therapeutics Announces Agreement To Joint Development Of A Self-Assembling Vaccine For The Potential Treatment Of The Coronavirus

March 23 (Reuters) - Hoth Therapeutics Inc:

* HOTH THERAPEUTICS ANNOUNCES AGREEMENT TO JOINT DEVELOPMENT OF A SELF-ASSEMBLING VACCINE (SAV) FOR THE POTENTIAL TREATMENT OF THE CORONAVIRUS (COVID-19)

* HOTH THERAPEUTICS INC - SAV TECHNOLOGY HAS BEEN LICENSED FROM MASSACHUSETTS GENERAL HOSPITAL

* HOTH THERAPEUTICS - PRECLINICAL DEVELOPMENT TO BE UNDERTAKEN IN CONJUNCTION WITH MASSACHUSETTS GENERAL HOSPITAL

* HOTH THERAPEUTICS INC - HOTH SHALL BE GRANTED RIGHT TO RECEIVE SINGLE DIGIT ROYALTIES FROM SALE OF ANY PRODUCTS DEVELOPED

* HOTH THERAPEUTICS INC - SHALL HAVE RIGHT TO ACQUIRE UP TO A 30% EQUITY INTEREST IN HALOVAX. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below